Related Experiment Videos
Minimal persistent inflammation may be controlled by cetirizine.
1Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa University, Italy.
Summary
Cetirizine effectively reduces nasal epithelial cell adhesion molecule expression and conjunctival hyperreactivity in children with mite allergy and minimal persistent inflammation (MPI). This highlights the importance of targeting MPI in allergy treatment strategies.
Area of Science:
- Immunology
- Allergology
- Respiratory Medicine
Background:
- Adhesion molecules, such as intracellular adhesion molecule-1 (ICAM-1), are critical in recruiting inflammatory cells during allergic reactions.
- ICAM-1 on nasal epithelial cells facilitates leukocyte infiltration and serves as a receptor for rhinoviruses, potentially linking allergies, infections, and asthma.
- Minimal persistent inflammation (MPI) in mite allergy is characterized by leukocyte infiltration and ICAM-1 expression, even without overt symptoms.
Purpose of the Study:
- To investigate the effects of an antiallergic drug on clinical aspects of minimal persistent inflammation (MPI) in mite allergy.
- To assess the impact of cetirizine on ICAM-1 expression and non-specific hyperreactivity.
Main Methods:
- Studies were conducted to evaluate the effects of an antiallergic drug on MPI.
- The drug's impact on ICAM-1 expression on nasal epithelial cells and conjunctival non-specific hyperreactivity was assessed.
Main Results:
- Cetirizine demonstrated a reduction in ICAM-1 expression on nasal epithelial cells.
- The drug also decreased conjunctival non-specific hyperreactivity in children with MPI.
Conclusions:
- Therapeutic strategies for mite allergy should focus on treating minimal persistent inflammation (MPI).
- Targeting ICAM-1 expression and associated inflammation is a viable approach for managing mite allergy.